Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost
Abstract Developing a safe and effective vaccine remains a global priority for ending the human immunodeficiency virus (HIV) pandemic. All HIV vaccine trials with protein, DNA, non-replication vector or their combinations failed in the past. We constructed the HIV-1 CN54 env, gag, and pol genes into...
Saved in:
| Main Authors: | Ying Liu, Wei Lv, Pu Shan, Dan Li, Ying-Qi Wu, You-Chun Wang, Yuan-Yuan Li, Qiang Liu, Jian-Sheng Wang, Yan-Ling Hao, Yong Liu, Wei-Jin Huang, Li Ren, Shu-Hui Wang, Tai-Sheng Li, Jing Xu, Yi-Ming Shao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02259-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
by: Getahun Abate, et al.
Published: (2025-05-01) -
Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
by: Hong Chen, et al.
Published: (2012-01-01) -
Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
by: Sugan Qiu, et al.
Published: (2014-01-01) -
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
by: Gavin Churchyard, et al.
Published: (2016-01-01) -
Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
by: Chunqing Gao, et al.
Published: (2024-09-01)